These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3447667)

  • 1. Selective decreases in MAO-B activity in post-mortem brains from schizophrenic patients with type II syndrome.
    Owen F; Crow TJ; Frith CD; Johnson JA; Johnstone EC; Lofthouse R; Owens DG; Poulter M
    Br J Psychiatry; 1987 Oct; 151():514-9. PubMed ID: 3447667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain and skeletal muscle monoamine oxidase activity in schizophrenia.
    Meltzer HY; Jackman H; Arora RC
    Schizophr Bull; 1980; 6(2):208-12. PubMed ID: 6103574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated postmortem monoamine oxidase B activity in the caudate nucleus in Huntington's disease compared to schizophrenics and controls.
    Mann JJ; Kaplan RD; Bird ED
    J Neural Transm; 1986; 65(3-4):277-83. PubMed ID: 2940336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain monoamine oxidase activity in schizophrenics and controls.
    Reveley MA; Glover V; Sandler M; Spokes EG
    Arch Gen Psychiatry; 1981 Jun; 38(6):663-5. PubMed ID: 7247629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Brain monoamine oxidase in schizophrenia].
    Moskvitina TA; Kamyshanskaia NS; Smirnov AV; Prilipko LL; Gorkin VZ
    Biull Eksp Biol Med; 1985 Jun; 99(6):671-2. PubMed ID: 4016256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective reduction of monoamine oxidase A and B in the frontal cortex of subordinate rats.
    Dhingra NK; Raju TR; Meti BL
    Brain Res; 1997 May; 758(1-2):237-40. PubMed ID: 9203554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Defect in the properties of brain mitochondrial monoamine oxidase in schizophrenia].
    Moskvitina TA; Kamyshanskaia NS; Gorkin VZ
    Vopr Med Khim; 1986; 32(1):98-102. PubMed ID: 3953020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortex.
    Kornhuber J; Konradi C; Mack-Burkhardt F; Riederer P; Heinsen H; Beckmann H
    Brain Res; 1989 Oct; 499(1):81-6. PubMed ID: 2804672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related increases in brain monoamine oxidase B in living healthy human subjects.
    Fowler JS; Volkow ND; Wang GJ; Logan J; Pappas N; Shea C; MacGregor R
    Neurobiol Aging; 1997; 18(4):431-5. PubMed ID: 9330975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demographic, biologic, and other variables affecting monoamine oxidase activity.
    Robinson DS; Nies A
    Schizophr Bull; 1980; 6(2):298-307. PubMed ID: 7375862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase-A and -B activities in the brain stem of schizophrenics and non-schizophrenic psychotics.
    Fowler CJ; Carlsson A; Winblad B
    J Neural Transm; 1981; 52(1-2):23-32. PubMed ID: 7288435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen peroxide enhances the activity of monoamine oxidase type-B but not of type-A: a pilot study.
    Konradi C; Riederer P; Youdim MB
    J Neural Transm Suppl; 1986; 22():61-73. PubMed ID: 3097261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography.
    Gulyás B; Pavlova E; Kása P; Gulya K; Bakota L; Várszegi S; Keller E; Horváth MC; Nag S; Hermecz I; Magyar K; Halldin C
    Neurochem Int; 2011 Jan; 58(1):60-8. PubMed ID: 21075154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase-A and B activities in the cerebellum and frontal cortex of children and young adults with autism.
    Gu F; Chauhan V; Chauhan A
    J Neurosci Res; 2017 Oct; 95(10):1965-1972. PubMed ID: 28151561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet monoamine oxidase activity in acute schizophrenia: relationship to symptomatology and neuroleptic medication.
    Owen F; Bourne RC; Crow TJ; Fadhli AA; Johnstone EC
    Br J Psychiatry; 1981 Jul; 139():16-22. PubMed ID: 7296184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous modulation of monoamine oxidase in schizophrenic and normal humans.
    Becker RE; Giambalvo CT
    Am J Psychiatry; 1982 Dec; 139(12):1567-70. PubMed ID: 7149055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional serotonin metabolism in the brain of transgenic mice lacking monoamine oxidase A.
    Popova NK; Gilinsky MA; Amstislavskaya TG; Morosova EA; Seif I; De Maeyer E
    J Neurosci Res; 2001 Nov; 66(3):423-7. PubMed ID: 11746359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients.
    Schildkraut JJ; Herzog JM; Orsulak PJ; Edelman SE; Shein HM; Frazier SH
    Am J Psychiatry; 1976 Apr; 133(4):438-40. PubMed ID: 1267046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase in chronic schizophrenia: Studies of hormonal and other factors affecting enzyme activity.
    Murphy DL; Belmaker R; Carpenter WT; Wyatt RJ
    Br J Psychiatry; 1977 Feb; 130():151-8. PubMed ID: 319862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease.
    Sherif F; Gottfries CG; Alafuzoff I; Oreland L
    J Neural Transm Park Dis Dement Sect; 1992; 4(3):227-40. PubMed ID: 1627256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.